title: Indications for implantable cardioverter-defibrillator placement in ischemic cardiomyopathy and after myocardial infarction.
abstract: Dramatic reductions in the rate of sudden cardiac death due to use of implantable cardioverter-defibrillators (ICDs) have been well-established in several large randomized clinical trials including patients with left ventricular dysfunction after myocardial infarction. This article reviews the literature regarding ICD utilization in the postinfarction population, with a strong emphasis on recent clinical trials. The most current indications for, and timing of, ICD implantation postinfarction also are summarized.
authors.affiliation: Cardiovascular Division, Department of Medicine, University of Pennsylvania, 3,400 Spruce Street, 9 Founders Pavilion, Philadelphia, PA 19104, USA.
authors.forename: Stavros E
authors.initials: SE
authors.lastname: Mountantonakis
authors.forename: Mathew D
authors.initials: MD
authors.lastname: Hutchinson
mesh_terms: D001145:Arrhythmias, Cardiac / Q000209:etiology / Q000628:therapy*; D058406:Cardiac Resynchronization Therapy; D009202:Cardiomyopathies / Q000150:complications* / Q000503:physiopathology; D016757:Death, Sudden, Cardiac / Q000517:prevention & control; D017147:Defibrillators, Implantable / Q000706:statistics & numerical data; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications* / Q000503:physiopathology; D017410:Practice Guidelines as Topic; D018487:Ventricular Dysfunction, Left / Q000150:complications